Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2 (Q44186907)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 1991

edit

Language	Label	Description	Also known as
English	Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2	scientific article published on January 1, 1991

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

title

Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2 (English)

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

main subject

interleukins

0 references

immunotherapy

1 reference

based on heuristic

inferred from title

oncology

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

author name string

P. Lissoni

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

retrieved

5 December 2022

E. Tisi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

retrieved

5 December 2022

F. Brivio

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

retrieved

5 December 2022

S. Barni

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

retrieved

5 December 2022

F. Rovelli

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

retrieved

5 December 2022

M. Perego

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

retrieved

5 December 2022

G. Tancini

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832885

retrieved

5 December 2022

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

1832885

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832885

retrieved

5 December 2022

publication date

1 January 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:027753799190271E?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

https://api.elsevier.com/content/article/PII:027753799190271E?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

published in

European Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

page(s)

1014-1016

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

cites work

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Recombinant interleukin-2 by continuous infusion and adoptive transfer of recombinant interleukin-2-activated cells in patients with advanced cancer

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Suppressor Cells in Neoplastic Disease

series ordinal

6

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Suppression of cell-mediated tumour immunity by Corynebacterium parvum

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1016/0277-5379(91)90271-E

reference URL

https://api.crossref.org/works/10.1016/0277-5379(91)90271-E

retrieved

5 December 2022

Identifiers

DOI

10.1016/0277-5379(91)90271-E

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

PubMed publication ID

1832885

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1832885

retrieved

30 November 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44186907&oldid=1784920839"